查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1901543

影像生物标记市场：按类型、技术、应用、最终用户、国家和地区划分－全球产业分析、市场规模、市场份额及2025-2032年预测

Imaging Biomarkers Market, By Type, By Technology, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 396 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年成像生物标记市场规模为 136.7845 亿美元，从 2025 年到 2032 年将以 12.5% 的复合年增长率成长。

影像生物标记市场正快速扩张，这主要得益于定量成像、人工智慧分析和精准医疗技术的进步。影像生物标记能够对生理、分子和结构过程进行非侵入性评估，进而改善疾病诊断、预后和治疗监测。磁振造影（MRI）、电脑断层扫描（CT）、正子断层扫描（PET）和超音波等影像方式正被越来越多地用于提取可测量的影像指标，这些指标可作为临床试验和个人化治疗方案中的替代终点。对疾病早期检测的需求不断增长、临床研究的增加以及放射组学和机器学习技术的整合进一步推动了市场成长。然而，该市场也面临一些限制因素，例如成像系统和生物标记验证成本高昂，以及缺乏标准化的成像方案。

影像生物标记市场－市场动态

技术进步

近年来，随着分子诊断技术的显着进步，影像生物标记领域蓬勃发展。 Cizzle Biotech 于 2025 年 3 月推出了 CIZ1B 生物标记检测，这是一种用于早期肺癌检测的非侵入性血液检测。此检测可作为 CT 和 PET 扫描等影像诊断程序的补充，用于识别高风险族群，从而使他们能够儘早接受治疗，并改善诊断流程。与 iGenomeDX 的合作将使该检测在美国获得可扩展的推广应用，提高分子和影像生物标记的可及性并促进其应用。

影像生物标记市场細項分析：

全球影像生物标记市场按类型、技术、应用、最终用户和地区进行细分。

根据类型，市场可分为三大类：试剂盒、仪器系统和软体服务。试剂盒因其检测频率高而占据主导地位，仪器系统支援自动化和高精度，而软体服务则可实现高效的资料分析、工作流程管理和整合。

根据技术类型，市场可分为六大类：PCR、次世代定序 (NGS)、原位杂交、晶片和微阵列、质谱以及其他技术。 NGS 可实现基因组分析；原位杂交可提供空间分析；微阵列和质谱可提高多重检测能力和精确度；而其他技术则支援专业化和新兴的诊断应用。

影像生物标记市场—地域性洞察

2025年影像生物标记市场呈现显着的地理分布特征，其中北美市场占据主导地位。北美市场占据显着份额，主要得益于其强劲的研发活动、先进的医疗基础设施、高发生率的慢性病和传染病以及对个人化医疗的迫切需求。该地区受益于对医疗保健和生物技术的巨额投资，推动了分子诊断技术在医院、实验室和研究中心的广泛应用。亚太地区成为成长最快的地区，其成长动力来自不断增长的医疗保健支出、政府为改善医疗基础设施而采取的各项倡议、日益严重的传染病和慢性病以及技术的进步。欧洲市场规模庞大，这得益于不断增长的研发投入和人口老化，从而推动了对影像生物标记的需求成长。其他地区，例如拉丁美洲和中东及非洲，也因医疗基础设施的改善和疾病负担的加重而呈现市场成长态势。

影像生物标记市场—国家概况

美国影像生物标记市场呈现显着的复合年增长率。这一增长主要得益于诊断技术的进步、个人化医疗需求的不断增长以及美国传染病和癌症发病率的上升。美国医疗体系对疾病早期检测和精准医疗的重视，促进了影像生物标记在医院、诊断中心和研究机构的广泛应用。液体活检和新一代定序（NGS）等关键技术正被越来越多地用于提高诊断准确性和标靶治疗的选择，尤其是在肿瘤学领域。此外，新冠肺炎、流感和爱滋病等传染病的日益普及也推动了对快速、准确的分子检测的需求。

目录

第一章：影像生物标记市场概述

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
  • 竞争洞察

第三章：影像生物标记市场主要趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场未来趋势

第四章：影像生物标记产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：影像生物标记市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：影像生物标记市场概况

  • 2024年影像生物标记市场占有率分析
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：影像生物标记市场：依类型划分

  • 概述
    • 细分市场占有率分析：按类型
    • 试剂和试剂盒
    • 仪器与系统
    • 软体与服务

第八章：成像生物标记市场：依技术划分

  • 概述
    • 细分市场占有率分析：依技术划分
    • PCR
    • 下一代定序（NGS）
    • 原位杂交
    • 晶片与微阵列
    • 质谱分析
    • 其他技术

第九章：影像生物标记市场：依应用领域划分

  • 概述
    • 细分市场占有率分析：按应用
    • 肿瘤学
      • 乳癌
      • 摄护腺癌
      • 大肠直肠癌
      • 其他的
    • 传染病
      • 呼吸道感染
      • 性传染感染
      • 血液传染感染
      • 结核分枝桿菌和非结核分枝桿菌
      • 其他的
    • 药物基因组学
    • 微生物学
    • 遗传疾病筛检
    • 人类白血球抗原分型
    • 血液筛检
    • 其他的

第十章：影像生物标记市场：依最终用户划分

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院
    • 诊断与参考实验室
    • 学术与研究机构
    • 其他最终用户

第十一章：影像生物标记市场：依地域划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • その他
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • その他
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • その他

第十二章：主要供应商分析：影像生物标记产业

  • 竞争格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • BD
    • Abbott
    • F. Hoffmann-La Roche, Ltd.
    • Agilent Technologies, Inc.
    • Danaher Corporation
    • Siemens Healthineers AG
    • Agilent Technologies Inc.
    • Hologic Inc. (Gen Probe)
    • Sysmex Corporation
    • Illumina Inc.
    • Others

第十三章：360度AnalystView

简介目录
Product Code: ANV5818

The Imaging Biomarkers Market size was valued at US$ 13,678.45 Million in 2024, expanding at a CAGR of 12.5% from 2025 to 2032.

The imaging biomarkers market is expanding rapidly, driven by advancements in quantitative imaging, AI-based analysis, and precision medicine. Imaging biomarkers enable the noninvasive assessment of physiological, molecular, and structural processes, improving disease diagnosis, prognosis, and therapy monitoring. Modalities such as MRI, CT, PET, and ultrasound are increasingly used to extract measurable imaging metrics that act as surrogate endpoints in clinical trials and personalized treatment plans. Rising demand for early disease detection, growth in clinical research, and integration of radiomics and machine learning technologies further propel market growth. The market faces restraints such as high costs of imaging systems and biomarker validation, lack of standardized imaging protocols.

Imaging Biomarkers Market- Market Dynamics

Technological advancements

The imaging biomarkers sector has grown in recent years as a result of significant improvements in molecular diagnostics. Cizzle Biotech launched the CIZ1B biomarker assay in March 2025, a non-invasive blood test for detecting lung cancer at an early stage. This assay can be used to supplement imaging-based diagnostic procedures like as CT and PET scans by detecting high-risk individuals, allowing them to be treated sooner, and improving diagnostic processes. The collaboration with iGenomeDX will give scalable access in the United States, enhancing accessibility and enabling the use of molecular and imaging biomarkers.

Imaging Biomarkers Market- Segmentation Analysis:

The Global Imaging Biomarkers Market is segmented on the basis of Type, Technology, Application, End User, and Region.

The market is divided into three categories based on Type: Reagents & Kits, Instruments & Systems, and Software & Services. Reagents & kits dominate due to high testing frequency, while instruments & systems support automation and accuracy, and software & services enable efficient data analysis, workflow management, and integration.

The market is divided into six categories based on Technology: PCR, Next-Generation Sequencing (NGS), In Situ Hybridization, Chips & Microarrays, Mass Spectrometry, and Other Technologies. NGS enables genomic profiling; In situ Hybridization offers spatial analysis; microarrays and mass spectrometry enhance multiplexing and precision, while other technologies support specialised and emerging diagnostic applications.

Imaging Biomarkers Market- Geographical Insights

The Imaging Biomarkers market exhibits significant geographical insights in 2025, with North America leading as the largest market. North America captures a significant market share, driven by robust research and development activities, advanced healthcare infrastructure, high prevalence of chronic and infectious diseases, and strong demand for personalised medicine. The region benefits from substantial investments in healthcare and biotechnology, contributing to widespread adoption of molecular diagnostic technologies in hospitals, laboratories, and research centres. Asia Pacific emerges as the fastest-growing region, which is fueled by increasing healthcare spending, expanding government initiatives to enhance healthcare infrastructure, rising prevalence of infectious and chronic diseases, and technological advancements. Europe holds a significant market size with growing investments in research and an ageing population, contributing to increasing demand for Imaging Biomarkers. Other regions, such as Latin America and the Middle East & Africa, are also witnessing market growth due to improving healthcare infrastructure and rising disease burden.

Imaging Biomarkers Market- Country Insights

The United States Imaging Biomarkers market was reflecting a significant CAGR. This growth is primarily driven by advancements in diagnostic technologies, increasing demand for personalised medicine, and a rising incidence of infectious diseases and cancer in the country. The U.S. healthcare system's focus on early disease detection and precision medicine contributes to the widespread adoption of Imaging Biomarkers across hospitals, diagnostic centres, and research institutions. Key technologies such as liquid biopsy and next-generation sequencing (NGS) are increasingly utilised to enhance diagnostic accuracy and targeted therapy selection, especially in oncology. Additionally, the rising prevalence of infectious diseases like COVID-19, influenza, and HIV fuels demand for rapid and accurate molecular testing.

Imaging Biomarkers Market- Competitive Landscape:

The Imaging Biomarkers market's competitive landscape in 2025 is led by several major global players that drive innovation and market growth through robust Type portfolios, technological advancements, and strategic expansions. For instance, in August 2024, Sysmex Corporation expanded its strategic alliance with QIAGEN to deepen collaboration in genetic testing, covering research and development, Typeion, clinical trials, and global sales and marketing. This alliance builds upon their initial 2021 partnership focused on cancer companion diagnostics using ultra-sensitive liquid biopsy NGS technology. Additionally, the market players are actively engaged in Type launches, regulatory approvals, acquisitions, and partnerships to enhance their market presence. Moreover, the collaborative efforts of market players, coupled with continuous R&D, enable the Imaging Biomarkers market to grow robustly, addressing diverse clinical needs globally.

Recent Developments:

In March 2025, Danaher Corporation, through subsidiaries like Beckman Coulter, is investing in automated and high-throughput molecular diagnostic solutions to support diverse clinical needs.

In February 2023, Becton Dickinson (BD) received FDA Emergency Use Authorisation (EUA) for a molecular diagnostic test capable of detecting and differentiating COVID-19, influenza A/B, and respiratory syncytial virus (RSV). This test, designed for use on the BD MAX Molecular Diagnostic System, uses a single nasal or nasopharyngeal swab sample.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMAGING BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BD
  • Abbott
  • F. Hoffmann-La Roche, Ltd.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Agilent Technologies Inc.
  • Hologic Inc. (Gen Probe)
  • Sysmex Corporation
  • Illumina Inc.
  • Others

GLOBAL IMAGING BIOMARKERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Reagents & Kits
  • Instruments & Systems
  • Software & Services

GLOBAL IMAGING BIOMARKERS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR
  • Next-Generation Sequencing (NGS)
  • In Situ Hybridization
  • Chips & Microarrays
  • Mass Spectrometry
  • Other Technologies

GLOBAL IMAGING BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
  • Infectious Disease
  • Respiratory Infections
  • Sexually Transmitted Infections
  • Blood-borne Infections
  • Tuberculosis & Non-tuberculous Mycobacteria
  • Others
  • Pharmacogenomics
  • Microbiology
  • Genetic Disease Screening
  • Human Leukocyte Antigen Typing
  • Blood Screening
  • Others

GLOBAL IMAGING BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic & Reference Laboratories
  • Academic & Research Institutes
  • Other End Users

GLOBAL IMAGING BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Imaging Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Imaging Biomarkers Market Snippet by Type
    • 2.1.2. Imaging Biomarkers Market Snippet by Technology
    • 2.1.3. Imaging Biomarkers Market Snippet by Application
    • 2.1.4. Imaging Biomarkers Market Snippet by End User
    • 2.1.5. Imaging Biomarkers Market Snippet by Country
    • 2.1.6. Imaging Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. Imaging Biomarkers Key Market Trends

  • 3.1. Imaging Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Imaging Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Imaging Biomarkers Market Opportunities
  • 3.4. Imaging Biomarkers Market Future Trends

4. Imaging Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Imaging Biomarkers Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Imaging Biomarkers Market Landscape

  • 6.1. Imaging Biomarkers Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Imaging Biomarkers Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Reagents & Kits
    • 7.1.3. Instruments & Systems
    • 7.1.4. Software & Services

8. Imaging Biomarkers Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. PCR
    • 8.1.3. Next-Generation Sequencing (NGS)
    • 8.1.4. In Situ Hybridization
    • 8.1.5. Chips & Microarrays
    • 8.1.6. Mass Spectrometry
    • 8.1.7. Other Technologies

9. Imaging Biomarkers Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Oncology
      • 9.1.2.1. Breast Cancer
      • 9.1.2.2. Prostate Cancer
      • 9.1.2.3. Colorectal Cancer
      • 9.1.2.4. Others
    • 9.1.3. Infectious Disease
      • 9.1.3.1. Respiratory Infections
      • 9.1.3.2. Sexually Transmitted Infections
      • 9.1.3.3. Blood-borne Infections
      • 9.1.3.4. Tuberculosis & Non-tuberculous Mycobacteria
      • 9.1.3.5. Others
    • 9.1.4. Pharmacogenomics
    • 9.1.5. Microbiology
    • 9.1.6. Genetic Disease Screening
    • 9.1.7. Human Leukocyte Antigen Typing
    • 9.1.8. Blood Screening
    • 9.1.9. Others

10. Imaging Biomarkers Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic & Reference Laboratories
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Other End Users

11. Imaging Biomarkers Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Imaging Biomarkers Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Imaging Biomarkers Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Imaging Biomarkers Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Imaging Biomarkers Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Imaging Biomarkers Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Imaging Biomarkers Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. BD
    • 12.2.2. Abbott
    • 12.2.3. F. Hoffmann-La Roche, Ltd.
    • 12.2.4. Agilent Technologies, Inc.
    • 12.2.5. Danaher Corporation
    • 12.2.6. Siemens Healthineers AG
    • 12.2.7. Agilent Technologies Inc.
    • 12.2.8. Hologic Inc. (Gen Probe)
    • 12.2.9. Sysmex Corporation
    • 12.2.10. Illumina Inc.
    • 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us